Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir dose-ranging study for herpes zoster
ChiCTR2100042275Phase 4Recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of valaciclovir in herpes zoster (HZ) (3 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Pain score (VAS). Started Jan 2021; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2100042275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042275.